NASDAQ:MIST

Milestone Pharmaceuticals Stock Predictions

etoro logo Buy MIST
*Your capital is at risk
$1.28
-0.0400 (-3.03%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

MIST Prediction Chart

MIST Predictions History

Latest community submissions for MIST.
Predictor Target Session Target Price Result Direction Accuracy Score
Mar 11, 2026 $1.74 -2.08% $1.71 V 98.07% 1
Mar 11, 2026 $1.76 -1.30% $1.71 V 97.26% 1
Mar 11, 2026 Bullish $1.71 X 0
Feb 25, 2026 $1.70 -2.37% $1.73 V 98.20% 1
Feb 25, 2026 $1.71 -1.48% $1.73 V 99.09% 2
Feb 25, 2026 Bullish $1.73 X 0
Jan 28, 2026 Bullish $1.94 X 0
Nov 17, 2025 $1.95 -2.32% $2.32 X 84.21% 0
Nov 17, 2025 $1.97 -1.45% $2.32 X 84.96% 0
Nov 17, 2025 $2.14 +12.63% $2.32 V 92.24% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for MIST with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT MILESTONE PHARMACEUTICALS INC.
Milestone Pharmaceuticals
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and ...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE